Vital Farms, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Director Kelly J. Kennedy was granted 10,436 restricted stock units in Vital Farms, Inc. as part of an equity compensation award.
NASDAQ
Director Kofi Owusu Amoo-Gottfried was granted 10,436 restricted stock units in Vital Farms, Inc.
NASDAQ
Vital Farms Director Gisel Ruiz was granted 10,436 restricted stock units as part of annual equity compensation.
NASDAQ
Director Denny Marie Post was granted 10,436 restricted stock units in Vital Farms, Inc. as part of an equity compensation award.
NASDAQ
Director Glenda J. Flanagan was granted 10,436 restricted stock units in Vital Farms, Inc. as part of equity compensation.
NASDAQ
Director William B. Cyr was granted 10,436 restricted stock units in Vital Farms, Inc.
NASDAQ
Director Karl Khoury was granted 10,436 restricted stock units in Vital Farms, Inc. as part of an equity compensation award.
NASDAQ
Vital Farms Chief People Officer Reena Chauhan Van Hoven acquired 2,242 shares of common stock on May 19, 2026.
NASDAQ
Vital Farms, Inc. reports that Director Glenda J. Flanagan acquired 6,100 shares of common stock.
NASDAQ
Vital Farms, Inc. reports an amendment to a Form 4 filing, clarifying a stock purchase by Director Kelly J. Kennedy.
NASDAQ
Vital Farms, Inc. reports an amendment to a Form 4 filing, clarifying a transaction where Director William B. Cyr acquired 6,000 shares of common stock.
NASDAQ
Vital Farms Chief Supply Chain Officer Joseph Michael Holland acquired 12,484 shares of common stock.
NASDAQ
Vital Farms director Glenda Flanagan purchased 6,100 shares of common stock at an average price of $8.33.
NASDAQ
Vital Farms Chief Strategy Officer Stephanie Coon acquired shares through the company's Employee Stock Purchase Plan.
NASDAQ
Russell Diez-Canseco, Vital Farms' Executive Chair, President & CEO, acquired 500 shares through the company's ESPP.
NASDAQ
Vital Farms Director Gisel Ruiz acquired 6,151 shares of common stock at $8.13 per share, with the transaction reported late due to an administrative delay.
NASDAQ
Vital Farms' Chief Financial Officer, Thilo Wrede, acquired 500 shares of common stock through the company's Employee Stock Purchase Plan on May 15, 2026.
NASDAQ
Joanne Bal, CLO, Secretary & Head of Impact at Vital Farms, Inc., acquired 500 shares of common stock through the company's Employee Stock Purchase Plan.
NASDAQ
Vital Farms, Inc. reports a Form 4 filing detailing a stock acquisition by Director Kofi Owusu Amoo-Gottfried.
NASDAQ
Vital Farms, Inc. Director Kelly J. Kennedy reported a sale of 2,500 shares of common stock on May 14, 2026, at a weighted average price of $8.40 per share.
NASDAQ
Vital Farms CMO and GM, Butter, Kathryn McKeon, acquired 604 shares of common stock on May 14, 2026.
NASDAQ
Vital Farms Director William B. Cyr reported a sale of 6,000 shares of common stock on May 14, 2026, at a weighted average price of $8.52 per share.
NASDAQ
Peter Pappas, CSO and President of Eggs at Vital Farms, acquired 3,500 shares of common stock.
NASDAQ
Joseph Michael Holland, Chief Supply Chain Officer at Vital Farms, Inc., reported a transaction involving the sale of 12,484 shares of common stock.
NASDAQ
Vital Farms director Denny Marie Post purchased 3,000 shares of common stock at a price of $8.23 per share.
NASDAQ
Vital Farms' Chief Financial Officer, Thilo Wrede, disposed of 3,192 shares of common stock to cover tax withholding obligations.
NASDAQ
Vital Farms' CMO and GM of Butter, Kathryn McKeon, reported the disposition of shares to cover tax obligations related to equity compensation.
NASDAQ
Vital Farms' CLO, Secretary, and Head of Impact, Joanne Bal, disposed of shares to cover tax obligations related to equity compensation.
NASDAQ
Vital Farms' President, CEO, and Executive Chair, Russell Diez-Canseco, disposed of shares to cover tax withholding obligations.
NASDAQ
Vital Farms' CSO and President, Eggs, Peter Nicholas Pappas, reported the withholding of shares to cover tax obligations related to equity compensation.